Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00804427 · ClinicalTrials.gov registry record · NA

Effect of Fish Oil on Plasma Triglycerides in Adults

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT00804427: Completed NA study, sponsored by Stanford University.

NCT00804427 is a NA study that has completed, run by Stanford University. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00804427, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The purpose of this small, short pilot study is to determine the feasibility (e.g., recruitment, dose acceptance, retention) of a future longer trial comparing the effects of two types of omega-3 fats from fish oil on plasma triglycerides. The two types of fish oil are composed of (1) omega-3 fatty acids in triglyceride form; and (2) as esterified free fatty acids (i.e. ethyl esters). Although these two types of fish oil supplements are available to the public, it remains unclear whether they are equally effective in lowering plasma triglycerides.

Primary Outcome

Change was calculated as the value at 3 months minus the value at baseline

Interventions

  • DIETARY_SUPPLEMENT Fish oil (90% triglycerides)
  • DIETARY_SUPPLEMENT Fish oil (60% triglycerides)
  • DIETARY_SUPPLEMENT Fish oil (ethyl esters)
  • DIETARY_SUPPLEMENT Soy oil

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2008-12
Est. Completion 2010-04
Phase NA
Stanford University

1,744 total trials

What the finished NCT00804427 record still lists

NCT00804427 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 4 interventions - of which Fish oil (90% triglycerides) is the first listed.

NCT00804427 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00804427 about?

NCT00804427 is a clinical study titled "Effect of Fish Oil on Plasma Triglycerides in Adults". The purpose of this small, short pilot study is to determine the feasibility (e.g., recruitment, dose acceptance, retention) of a future longer trial comparing the effects of two types of omega-3 fats from fish oil on plasma triglycerides. The two types of fish oil are composed of (1) omega-3 fatty ...

What is the current status of trial NCT00804427?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2008-12. Estimated completion is 2010-04.

What interventions are being tested in trial NCT00804427?

The interventions under investigation include: Fish oil (90% triglycerides) (DIETARY_SUPPLEMENT), Fish oil (60% triglycerides) (DIETARY_SUPPLEMENT), Fish oil (ethyl esters) (DIETARY_SUPPLEMENT), Soy oil (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00804427?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00804427's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00804427, the US trial registry maintained by the National Library of Medicine. NCT00804427 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.